Clinical trials
Phase 2 Multiple Myeloma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 7 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 7 |
| GlaxoSmithKline | 4 |
| AbbVie | 3 |
| Peter MacCallum Cancer Centre, Australia | 3 |
| Bristol-Myers Squibb | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| Bayside Health | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 32 |
| Recurrence | 10 |
| Neoplasms | 5 |
| Neoplasms, Plasma Cell | 5 |
| Lymphoma | 2 |
| Blood Protein Disorders | 1 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Immunoproliferative Disorders | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.